Women's Health Gaps & Innovations (Harvard Business School)

Summary for practice owners

This Harvard Business School panel brings together women's health innovators to discuss unmet needs, differences in how conditions affect women, and the path from research to commercial products. The opening frames sex differences as relevant across areas such as cardiovascular, autoimmune, brain health and maternal health. Speakers then describe diagnostic innovation and the importance of access, including a discussion of ovarian cancer testing and limitations in existing approaches. Later topics include a platform, regulatory frameworks, clinical trials, founding teams, customers, investors, medical devices and diagnostics. For OB-GYN practice owners, the panel offers a broad view of how new women's health products move through development and toward clinical use. It is a reminder to examine who a product was studied in, what need it addresses, how it fits into current workflows and what evidence supports its intended role. The discussion also connects clinical gaps with business realities: founders need capable teams, engaged customers, an appropriate regulatory path and capital. Practice leaders may encounter these products as potential tools, referral options or partnership opportunities, so understanding the development context can sharpen evaluation. The panel's emphasis on the inclusion of women in clinical research is especially relevant to owners who assess new diagnostics or devices for their practices. This industry discussion helps physician leaders situate innovation within a larger ecosystem of research and access. The speakers remain focused on the opportunity to improve women's health through better-designed innovations and broader awareness of the gaps.

Owner takeaways

• 2:40 Consider sex differences across multiple service lines when reviewing new tools and care models.
• 5:23 Assess whether a diagnostic innovation can be delivered in settings accessible to your patient community.
• 12:45 Track the regulatory pathway when evaluating a new women's health product.
• 34:12 Women's inclusion in clinical trials is a key lens for judging how broadly evidence may apply.
• 49:16 Keep the customer and workflow perspective in view when considering devices or diagnostics.

Why it made the list

The panel connects women's health gaps with product development, regulation and investment, useful context for physician owners. It has 64 views and 1 like.

Related videos

The Business Of Fertility And Why It Took So Long

What’s next in women’s health The biggest innovation opportunities for 2022

The Business of Gynecology in Canada w/ Dr. Jonathon Solnik | BackTable OBGYN Ep. 78

This video is published by G2G Consulting on YouTube. Obstetricians.com is not affiliated with the creator, and inclusion is not an endorsement by either party. Watch it on YouTube.